Eli Lilly Corp. buy BMO Capital Markets
Start price
03.07.24
/
50%
€842.00
Target price
03.07.25
€928.23
Performance (%)
-21.39%
End price
04.07.25
€661.90
Summary
This prediction ended on 04.07.25 with a price of €661.90. The price of Eli Lilly Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.39%. BMO_Capital_Markets has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. A total of €3.85 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -7.031% | -7.031% | 14.443% |
| iShares Core DAX® | 0.142% | -1.511% | 18.159% |
| iShares Nasdaq 100 | 0.833% | -2.600% | 9.025% |
| iShares Nikkei 225® | -0.829% | -7.040% | 10.142% |
| iShares S&P 500 | 0.008% | -1.196% | 3.094% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $1,001.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Eli Lilly Corp.
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-2.30%
02.05.25
02.05.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
28.09%
08.02.25
08.02.25